Xeris Biopharma Holdings, Inc. - XERS Net earnings per one share for the last twelve months

Xeris Biopharma Holdings, Inc. (XERS) - corporate logo

Xeris Biopharma (XERS) momentum is driven by the commercial success of Gvoke and Recorlev, as clearly demonstrated by the annual EPS TTM percentage growth on the GURU.Markets base chart. The current 63.80 metric confirms the efficiency level of XeriSol anhydrous solutions, which simplify injections. Stable management has solidified this trend, confidently steering the business toward a trajectory of operational profitability.

XERS: xerispharma.com Net earnings per share for the last 12 months 02/11/2024 - 11/18/2026

Xeris Biopharma - analytical breakdowns and key metrics (XERS)

Fundamental company valuation:XERS - Xeris Biopharma Holdings, Inc.
Brand item of Xeris Pharma

This metric measures the rolling year net income per share dynamics, allowing investors to assess business scaling rates and actual capitalization efficiency. For Xeris Biopharma (XERS), the EPS YoY TTM growth efficiency indicator verifies the financial return on production outsourcing, confirming that the reliability of CMO partner chains is transforming into sustainable growth in shareholder value.

Competitor analysis

Earnings per one share for the last 12 months VRTX|ALNY: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Insmed Inc (INSM)|UTHR (United Therapeutics Corporation) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months BMRN (BioMarin)|Net earnings per share for the last 12 months BBIO (BridgeBio)|BGM: Earnings per one share for the last 12 months|Earnings per share for the last twelve months Cogent Biosciences, Inc. COGT|KROS (Keros Pharma) - Earnings per one share for the last 12 months|Arcturus Therapeutics - Net earnings per share (EPS TTM)|Earnings per share for the trailing year ETON (Eton Pharmaceuticals)|KMDA: Net earnings per share (EPS TTM)|Fulcrum Therapeutics Inc (FULC) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months abeonatherapeutics.com|MREO: Earnings per share for the trailing year|Net earnings per share (EPS TTM) PLX|Net earnings per share for the last 12 months Pliant Therapeutics, Inc. PLRX|Net earnings per share (EPS TTM) APLT (Applied Therapeutics Inc.)|Net earnings per share (EPS TTM) Rein Therapeutics Inc. RNTX|gelteq.com - Net earnings per share (EPS TTM)|AYTU - Net earnings per share (EPS TTM)|CMMB: Net earnings per share (EPS TTM)|SRx Health Solutions Inc. - Earnings per share for the trailing year|Earnings per share for the last twelve months Polyrizon Ltd|AEZS (Aeterna Zentaris) - Earnings per share for the last four quarters|Earnings per share for the last twelve months CTD Holdings (CYTH)|INZY: Earnings per one share for the last 12 months|Earnings per share for the last twelve months Reneo Pharmaceuticals Inc. RPHM|Net earnings per share for the last four quarters COSCIENS Biopharma Inc. (CSCI)